The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.

The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.

We have studied the effects of the extracellular molecular chaperone, clusterin, on the in vitro aggregation of mutational variants of human lysozyme, including one associated with familial amyloid disease. The aggregation of the amyloidogenic variant I56T is inhibited significantly at clusterin to...

Bibliográfalaš dieđut
Váldodahkkit:	Kumita, JR, Poon, S, Caddy, G, Hagan, C, Dumoulin, M, Yerbury, J, Stewart, E, Robinson, C, Wilson, MR, Dobson, C
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2007

Geahča maid

Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
Dahkki: Johnson, R, et al.
Almmustuhtton: (2005)

The significance of the location of mutations for the native-state dynamics of human lysozyme
Dahkki: Ahn, M, et al.
Almmustuhtton: (2016)

The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
Dahkki: Patricia Yuste-Checa, et al.
Almmustuhtton: (2021-08-01)

The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
Dahkki: Abigail K. Elias, et al.
Almmustuhtton: (2022-10-01)

Expression and purification of chaperone-active recombinant clusterin.
Dahkki: Rebecca A Dabbs, et al.
Almmustuhtton: (2014-01-01)

Molecular mechanisms at the basis of the protective effect exerted by EPPS on neurodegeneration induced by prefibrillar amyloid oligomers
Dahkki: Beatrice Zarrilli, et al.
Almmustuhtton: (2024-11-01)

A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.
Dahkki: De Genst, E, et al.
Almmustuhtton: (2013)

A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis.
Dahkki: Hagan, C, et al.
Almmustuhtton: (2010)

Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.
Dahkki: Chan, P, et al.
Almmustuhtton: (2008)

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.
Dahkki: Dumoulin, M, et al.
Almmustuhtton: (2003)

Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris.
Dahkki: Kumita, JR, et al.
Almmustuhtton: (2006)

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
Dahkki: Booth, DR, et al.
Almmustuhtton: (1997)

Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain.
Dahkki: Krebs, MR, et al.
Almmustuhtton: (2000)

BIOT 243-Biophysical study of the aggregation of human lysozyme into amyloid fibrils
Dahkki: Dhulesia, A, et al.
Almmustuhtton: (2008)

Pathway Dependence of the Formation and Development of Prefibrillar Aggregates in Insulin B Chain
Dahkki: Yuki Yoshikawa, et al.
Almmustuhtton: (2022-06-01)

Astrocyte-derived clusterin suppresses amyloid formation in vivo
Dahkki: Aleksandra M. Wojtas, et al.
Almmustuhtton: (2020-11-01)

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
Dahkki: Rasool Suhail, et al.
Almmustuhtton: (2007-09-01)

Investigation of non-covalent interactions of amyloidogenic human lysozyme variants and camelid antibodies
Dahkki: Caddy, G, et al.
Almmustuhtton: (2002)

The conformation of lysozyme in solution
Dahkki: Dobson, C, et al.
Almmustuhtton: (1975)

Insights into amyloid fibril formation from mass spectrometry.
Dahkki: Caddy, G, et al.
Almmustuhtton: (2006)

Association of clusterin with the BRI2-derived amyloid molecules ABri and ADan
Dahkki: Agueda Rostagno, et al.
Almmustuhtton: (2021-10-01)

Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo
Dahkki: Marie Violet, et al.
Almmustuhtton: (2015-10-01)

Conformational dynamics and protein unfolding in lysozyme amyloidosis
Dahkki: Sunde, M, et al.
Almmustuhtton: (1999)

Interaction of the molecular chaperone alpha B-crystallin with alpha-synuclein: Effects on amyloid fibril formation and chaperone activity
Dahkki: Rekas, A, et al.
Almmustuhtton: (2004)

Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
Dahkki: Rekas, A, et al.
Almmustuhtton: (2004)

Clusterin is required for β-Amyloid toxicity in human iPSC-derived neurons
Dahkki: Robbins, J, et al.
Almmustuhtton: (2018)

Effects of model membranes on lysozyme amyloid aggregation
Dahkki: Burrelli Annaclaudia, et al.
Almmustuhtton: (2023-08-01)

Effect of Silica Nanoparticles on the Amyloid Fibrillation of Lysozyme
Dahkki: Mouli Konar, et al.
Almmustuhtton: (2019-01-01)

Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
Dahkki: Dumoulin, M, et al.
Almmustuhtton: (2005)

Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy
Dahkki: Yoshinori Endo, et al.
Almmustuhtton: (2019-01-01)

Kinetic consequences of the removal of a disulfide bridge on the folding of hen lysozyme.
Dahkki: Eyles, S, et al.
Almmustuhtton: (1994)

Characterisation of the dominant oxidative folding intermediate of hen lysozyme.
Dahkki: van den Berg, B, et al.
Almmustuhtton: (1999)

Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer
Dahkki: Dong Choon Park, et al.
Almmustuhtton: (2008-09-01)

Structure of hen lysozyme in solution.
Dahkki: Smith, L, et al.
Almmustuhtton: (1993)

Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers
Dahkki: Yeung Stephen, et al.
Almmustuhtton: (2010-12-01)

Molecular recycling within amyloid fibrils.
Dahkki: Carulla, N, et al.
Almmustuhtton: (2005)

The Interaction between Amyloid Prefibrillar Oligomers of Salmon Calcitonin and a Lipid-Raft Model: Molecular Mechanisms Leading to Membrane Damage, Ca<sup>2+</sup>-Influx and Neurotoxicity
Dahkki: Marco Diociaiuti, et al.
Almmustuhtton: (2019-12-01)

BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides
Dahkki: John Zhou, et al.
Almmustuhtton: (2023-05-01)

Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study
Dahkki: José Rafael Romero, et al.
Almmustuhtton: (2020-07-01)

The origin of the alpha-domain intermediate in the folding of hen lysozyme.
Dahkki: Matagne, A, et al.
Almmustuhtton: (1998)